Peritoneal Cancer Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Clinical Trials

A Phase II Study Evaluating the Effect of GEN-1 on SLL When Administered in Combination With Bevacizumab and NACT in Subjects Newly Diagnosed With Advanced Ovarian, Fallopian Tube or Primary Peritoneal Cancer
Conditions:   Ovarian Cancer;   Fallopian Tube Cancer;   Primary Peritoneal Cancer Interventions:   Drug: Paclitaxel;   Drug: Carboplatin;   Drug: Bevacizumab;   Drug: GEN1 Sponsors:   Imunon;   Break Through Cancer Foundation Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 22, 2023 Category: Research Source Type: clinical trials

MT2021-27 FT538 Recurrent Ovarian, Fallopian Tube, and Primary Peritoneal Cancer
Conditions:   Cancer;   Solid Tumor;   Ovarian Cancer;   Peritoneal Cancer;   Fallopian Tube Cancer Interventions:   Drug: FT538;   Biological: Enoblituzumab Sponsor:   Masonic Cancer Center, University of Minnesota Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 1, 2023 Category: Research Source Type: clinical trials